The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?

Transplant International

Volumn 26, Issue 11, 2013, Pages 1070-1079

  Al Freah, Mohammad A B ^a   Kriese, Stephen ^a   Foxton, Matthew R ^a   Quaglia, Alberto ^a   Bomford, Adrian ^a   Heaton, Nigel D ^a   O'Grady, John G ^a   Agarwal, Kosh ^a   Wendon, Julia A ^a   Heneghan, Michael A ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

hepatic; iron; mortality; transplantation

Indexed keywords

FERRITIN;

ADULT; AGE; AGED; ARTICLE; COLD ISCHEMIA; FEMALE; FERRITIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER HEMOSIDEROSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; POST TREATMENT SURVIVAL; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TREATMENT OUTCOME; ADOLESCENT; BLOOD; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; LIVER DISEASE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; MORTALITY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SIDEROSIS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; FERRITINS; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIDEROSIS; WAITING LISTS;

EID: 84886833723     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12164     Document Type: Article

References (42)

1. Kamath PS, Wiesner RH, Malinchoc M, et al,. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
2. Luca A, Angermayr B, Bertolini G, et al,. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007; 13: 1174.
3. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG,. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336.
4. Kim WR, Biggins SW, Kremers WK, et al,. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018.
5. Barber K, Madden S, Allen J, Collett D, Neuberger J, Gimson A,. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation 2011; 92: 469.
6. Walker NM, Stuart KA, Ryan RJ, et al,. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology 2010; 51: 1683.
7. Jacob M, Copley LP, Lewsey JD, et al,. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004; 10: 903.
8. Desai NM, Mange KC, Crawford MD, et al,. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004; 77: 99.
9. Habib S, Berk B, Chang CC, et al,. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006; 12: 440.
10. Weismuller TJ, Kirchner GI, Scherer MN, et al,. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival. Hepatology 2011; 54: 2114.
11. Scheuer PJ, Lefkowitch JH,. eds. Liver biopsy interpretation. 6th edn. W. B. Saunders, London, 2000.
12. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R,. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646.
13. Feng S, Goodrich NP, Bragg-Gresham JL, et al,. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
14. Mazzaferro V, Regalia E, Doci R, et al,. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
15. World Health Organization, Obesity and overweight, 2012:Fact sheet No 311.
16. Youden WJ,. Index for rating diagnostic tests. Cancer 1950; 3: 32.
17. Maluf DG, Edwards EB, Kauffman HM,. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation 2006; 82: 1653.
18. Wang J, Pantopoulos K,. Regulation of cellular iron metabolism. Biochem J 2011; 434: 365.
19. Franchini M,. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment. Am J Hematol 2006; 81: 202.
20. Zandman-Goddard G, Shoenfeld Y,. Ferritin in autoimmune diseases. Autoimmun Rev 2007; 6: 457.
21. Kalantar-Zadeh K, Lee GH,. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol 2006; 1 (Suppl 1): S9.
22. Ford ES, Cogswell ME,. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999; 22: 1978.
23. Jehn M, Clark JM, Guallar E,. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004; 27: 2422.
24. Armand P, Kim HT, Rhodes J, et al,. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 852.
25. Henter JI, Horne A, Arico M, et al,. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124.
26. Kirkali Z, Guzelsoy M, Mungan MU, Kirkali G, Yorukoglu K,. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume. Urol Int 1999; 62: 21.
27. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV,. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 2003; 124: 318.
28. Bell H, Skinningsrud A, Raknerud N, Try K,. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med 1994; 236: 315.
29. Kowdley KV, Belt P, Wilson LA, et al,. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2012; 55: 77.
30. Planas R, Balleste B, Alvarez MA, et al,. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004; 40: 823.
31. Shetty K, Rybicki L, Carey WD,. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997; 25: 1049.
32. Lucey MR, Brown KA, Everson GT, et al,. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation 1998; 66: 956.
33. Wiesner R, Edwards E, Freeman R, et al,. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
34. Ripoll C, Banares R, Rincon D, Catalina MV,. Lo Iacono O, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005; 42: 793.
35. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A,. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10: 1.
36. Ghobrial RM, Gornbein J, Steadman R, et al,. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg. 2002; 236: 315; discussion 22.
37. Busuttil RW, Farmer DG, Yersiz H, et al,. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005; 241: 905; discussion 16.
38. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM,. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419.
39. Shedlofsky SI,. Role of iron in the natural history and clinical course of hepatitis C disease. Hepatogastroenterology 1998; 45: 349.
40. Giannini E, Mastracci L, Botta F, et al,. Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and alpha-glutathione S-transferase levels. Eur J Gastroenterol Hepatol 2001; 13: 1355.
41. Kowdley KV, Brandhagen DJ, Gish RG, et al,. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 2005; 129: 494.
42. Crawford DH, Fletcher LM, Hubscher SG, et al,. Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 2004; 39: 1655.